These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3309297)

  • 1. New drugs for mental diseases? New diseases for old drugs?
    Joyce CR
    J R Soc Med; 1987 Jul; 80(7):406-9. PubMed ID: 3309297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 3. The evaluation of new psychoactive drugs.
    Müller CP; Hassan Z
    Brain Res Bull; 2016 Sep; 126(Pt 1):1-2. PubMed ID: 27235862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of transformation in ridits for the evaluation of the activity of psychotropic drugs].
    Rovida S; Ravera GB
    Arch Maragliano Patol Clin; 1979; 35():41-6. PubMed ID: 263694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Planning of psychotropic drug trials. Statistical evaluation. Hypotheses and methods].
    Immich H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):185-92. PubMed ID: 30098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some problems in the conduct of psychotropic drug trials (a review).
    Doongaji DR; Parikh MD
    J Postgrad Med; 1983 Apr; 29(2):67-74. PubMed ID: 6631765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of psychotropic drugs].
    Nieto D
    Bol Estud Med Biol; 1974; Suppl 1():309-17. PubMed ID: 4619018
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of compliance.
    Sleator EK
    Psychopharmacol Bull; 1985; 21(4):1089-93. PubMed ID: 4089103
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patient (demented and non-demented).
    Pharmacopsychiatria; 1981 Nov; 14(6):217-22. PubMed ID: 7323142
    [No Abstract]   [Full Text] [Related]  

  • 10. On predicting therapeutic usefulness of psychotropic drugs from experiments in health persons.
    Spiegel R
    Rev Pure Appl Pharmacol Sci; 1980; 1(3):215-91. PubMed ID: 7025115
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicine. What are the right targets for psychopharmacology?
    Hyman SE; Fenton WS
    Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
    [No Abstract]   [Full Text] [Related]  

  • 12. [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].
    Woggon B
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):140-6. PubMed ID: 360238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnoses as selection criteria in drug trials.
    Buller R; Maier W
    Psychopharmacol Ser; 1990; 8():139-54. PubMed ID: 2198561
    [No Abstract]   [Full Text] [Related]  

  • 14. Time-blind evaluation of psychopathology in drug research.
    Bobon DP
    Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Taxonomy and assessment of psychological investigation methods in psychotropic drug trials (author's transl)].
    Baumann U; Seidenstücker G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):165-75. PubMed ID: 360241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and clinical assessment issues in the development and therapeutic evaluation of psychopharmacologic agents.
    Robinson DS; Roberts DL; Copp JE; Schwiderski U
    Psychopharmacol Bull; 1989; 25(1):9-15. PubMed ID: 2672074
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychiatric diagnoses and treatment with psychopharmaceuticals. Guidelines from the National Board of Health and Welfare].
    Adserballe H
    Ugeskr Laeger; 2001 Apr; 163(14):1998-9. PubMed ID: 11307360
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopharmacology. The medication merry-go-round.
    Brown K
    Science; 2003 Mar; 299(5613):1646-9. PubMed ID: 12637713
    [No Abstract]   [Full Text] [Related]  

  • 19. Time for a rethink?
    Boyce P
    Aust N Z J Psychiatry; 2013 Nov; 47(11):981-2. PubMed ID: 24198296
    [No Abstract]   [Full Text] [Related]  

  • 20. [New psychotropic drugs (review of the literature)].
    Kotikov GM; Lerner VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):132-43. PubMed ID: 2163155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.